Bringing the fundamentals into focus…
Back to Eli Lilly and Company
How Eli Lilly and Company stacks up
LLY · against 1,329 other Healthcare companies
Overall
63/ 100
Above the middle of the pack.
Ranked #315 of 1,330 · scores higher than 75% of peers
Bars: peers in each 10-point band of the overall score258 peers with an overall score of 60–69, including LLY · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around LLY| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.0B EUR (≈$3.3B) | 99 | 100 | 100 | 0 / 2 | ||
| 2 | 658M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 2.0B USD | 97 | 97 | 99 | 93 | 0 / 2 | |
| 2 | 238M USD | 97 | 94 | — | 98 | 0 / 2 | |
| 5 | 16.7B DKK (≈$2.5B) | 96 | 96 | 99 | 96 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score